GlaxoSmithKlein has issued a recall of three batches of albuterol inhalers due to a potential defect.

By Hollee Actman Becker
April 07, 2017
Credit: bubutu/Shutterstock

If your child suffers from asthma, you're going to want to pay close attention: GlaxoSmithKline is recalling more than 590,000 albuterol inhalers—used to deliver medication into the body through the airway and lungs—from U.S. hospitals, pharmacies, retailers, and wholesalers due to a potential defect that may cause them to deliver fewer doses of the medicine than needed.

Here's what you need to know: The affected lot numbers are 6ZP0003, 6ZP9944, and 6ZP9848. And while GSK has received an "elevated number of product complaints" about a bulging of the outside wrapper indicating a possible leak, according to a statement from the company, this is not a patient-level recall since the defect does not pose a danger to patients.

"Though the overall benefit-risk assessment for Ventolin® HFA 200D Inhaler when used at prescribed doses remains favorable, in this situation, there is possible risk to patients of experiencing diminished bronchodilation in the setting of acute bronchospasm if reliant on a rescue inhaler that could potentially not deliver the stated number of actuations," the statement reads. "GSK is committed to supplying high quality product and patient satisfaction, and we sincerely regret any inconvenience this recall may cause."

Credit: Asthma and Allergy Foundation of America

In the meantime, if you find one of these affected inhalers in your medicine cabinet, feel free to contact GSK customer service with any questions at 1-888-825-5249. And see more information from the FDA.

Hollee Actman Becker is a freelance writer, blogger, and mom of two who writes about parenting and pop culture. Check out her website for more, and then follow her on Instagram and Twitter.


Be the first to comment!